e-ISSN: Pending
Negative / Null Result ReportBiochemistry, Genetics and Molecular Biology· cited by 10

Modulation of autophagy: A phase II study of vorinostat (VOR) plus hydroxychloroquine (HCQ) vs regorafenib (RGF) in chemo-refractory metastatic colorectal cancer (mCRC).

Sukeshi Patel Arora; Laura Tenner; John Sarantopoulos; Jay Morris; Lisa Longoria; Qianqian Liu; Joel Michalek; Devalingam Mahalingam · 2019 · Journal of Clinical Oncology

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract (excerpt)

3551 Background: Agents targeting the angiogenic pathway have been a cornerstone therapy in mCRC. In chemo-refractory mCRC, RGF, an oral multikinase inhibitor with considerable angiogenic inhibition, has shown modest effects on survival.…

Excerpt shown for reference under fair use — read the full paper at the publisher.

Read full paper at publisher

Hosted by the publisher — may require access.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.1200/jco.2019.37.15_suppl.3551